Spinal Cord Stimulation in Patients With Disorders of Consciousness

Sponsor
Huashan Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04010838
Collaborator
(none)
40
1
2
48
0.8

Study Details

Study Description

Brief Summary

Disorders of consciousness(DOC) is the most serious complications and has been widely paid attention to by the government. DOC patients cause large social and economic burden to our society for there has no effective cure so far. Spinal cord stimulation(SCS) for wake-promoting therapy has aroused scholars' attention and become a hot area recently. There was much debate about the effectiveness of SCS therapy, but because of the limitation of our understanding of consciousness and the uncertainty of parameters of the stimulation, So, to figure out the indications and effectiveness of neuromodulation therapy should be the first step, and finding individual treatment and parameter may have important implications for DOC patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: spinal cord stimulation
N/A

Detailed Description

The spinal cord stimulation therapy is explorative at best at the moment. Attempts to improve the level of consciousness of patients in the different stages of DOC have shown some promise. Spinal cord stimulation(SCS) seem promising in some studies, suggesting that further research is needed. Current publications of DOC spinal cord stimulation therapy was not convincing because of the small number of patients and no randomized controlled trial. Therefore, there was much debate about the effectiveness of spinal cord stimulation therapy because of the limitation of our understanding of consciousness and the uncertainty of parameters of neuromodulation. The better understanding of brain function and large randomized trials are necessary. Future research should also focus on identifying specific neuro-biomarkers (i.e. neural network). So, to figure out the indications and effectiveness of neuromodulation therapy should be the first step, and finding individual treatment and parameter may have important implications for DOC patients.

Scientific Issues Targeted:1) To figure out the effectiveness of spinal cord stimulation therapy using random controlled trial. 2) To explore individual parameters of SCS techniques.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Random controlled trialRandom controlled trial
Masking:
Single (Outcomes Assessor)
Masking Description:
People who involved with data analysis and outcomes assessment would be blind to the randomization procedure.
Primary Purpose:
Treatment
Official Title:
Effectiveness Research for Severe Disorders of Consciousness Patients Treated With Spinal Cord Stimulation (SCS)
Anticipated Study Start Date :
Jul 1, 2019
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Conventional treatment

Experimental: Spinal cord stimulation and conventional treatment

Procedure: spinal cord stimulation
The spinal cord stimulation(SCS) is a type of implantable neuromodulation device (spinal cord stimulator) that is used to send electrical signals to select areas of the spinal cord (C2-C4 in this study) for the treatment of disorders of consciousness.

Outcome Measures

Primary Outcome Measures

  1. the JFK Coma Recovery Scale-Revised (CRS-R) scale [at baseline (T0), which means 1 month before stimulation.]

    The CRS-R is a tool used to characterise the level of consciousness.The CRS-R is a tool used to characterize the level of consciousness and to monitor neurobehavioural recovery in DOC. The scale consists of 23 hierarchically arranged items that comprise six subscales addressing the auditory, visual, motor, oromotor/verbal, communication and arousal processes. The lowest item on each subscale represents reflexive activity whereas the highest item represents cognitively mediated behaviors.

  2. the JFK Coma Recovery Scale-Revised (CRS-R) scale [2 weeks after the end of the treatment (T1)]

    The CRS-R is a tool used to characterise the level of consciousness.The CRS-R is a tool used to characterize the level of consciousness and to monitor neurobehavioural recovery in DOC. The scale consists of 23 hierarchically arranged items that comprise six subscales addressing the auditory, visual, motor, oromotor/verbal, communication and arousal processes. The lowest item on each subscale represents reflexive activity whereas the highest item represents cognitively mediated behaviors.

  3. the JFK Coma Recovery Scale-Revised (CRS-R) scale [3 months after the end of the treatment (T2)]

    The CRS-R is a tool used to characterise the level of consciousness.The CRS-R is a tool used to characterize the level of consciousness and to monitor neurobehavioural recovery in DOC. The scale consists of 23 hierarchically arranged items that comprise six subscales addressing the auditory, visual, motor, oromotor/verbal, communication and arousal processes. The lowest item on each subscale represents reflexive activity whereas the highest item represents cognitively mediated behaviors.

  4. the JFK Coma Recovery Scale-Revised (CRS-R) scale [6 months after the end of the treatment(T3)]

    The CRS-R is a tool used to characterise the level of consciousness.The CRS-R is a tool used to characterize the level of consciousness and to monitor neurobehavioural recovery in DOC. The scale consists of 23 hierarchically arranged items that comprise six subscales addressing the auditory, visual, motor, oromotor/verbal, communication and arousal processes. The lowest item on each subscale represents reflexive activity whereas the highest item represents cognitively mediated behaviors.

Secondary Outcome Measures

  1. EEG recording in resting state with Phase Coherence analysis(PC index) [at baseline (T0), which means 1 month before stimulation.]

    EEG data will be collected using a 256-channel EEG recording system(GES300, Electrical Geodesic, Inc., USA). Phase Coherence index will be performed in MATLAB by first taking the phase of the spectral signals(A), and the caculating as the following: mean[cos(A),2]^2 + mean[sin(A),2]^2

  2. EEG recording in resting state with Phase Coherence analysis(PC index) [2 weeks after the end of the treatment (T1)]

    EEG data will be collected using a 256-channel EEG recording system(GES300, Electrical Geodesic, Inc., USA). Phase Coherence index will be performed in MATLAB by first taking the phase of the spectral signals(A), and the caculating as the following: mean[cos(A),2]^2 + mean[sin(A),2]^2

  3. EEG recording in resting state with Phase Coherence analysis(PC index) [3 months after the end of the treatment (T2)]

    EEG data will be collected using a 256-channel EEG recording system(GES300, Electrical Geodesic, Inc., USA). Phase Coherence index will be performed in MATLAB by first taking the phase of the spectral signals(A), and the caculating as the following: mean[cos(A),2]^2 + mean[sin(A),2]^2

  4. EEG recording in resting state with Phase Coherence analysis(PC index) [6 months after the end of the treatment (T3)]

    EEG data will be collected using a 256-channel EEG recording system(GES300, Electrical Geodesic, Inc., USA). Phase Coherence index will be performed in MATLAB by first taking the phase of the spectral signals(A), and the caculating as the following: mean[cos(A),2]^2 + mean[sin(A),2]^2

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients ages 14 to 65 years old;

  2. DOC patients, including vegetative state and minimally consciousness state.

  3. With normal body temperature, stable vital signs, spontaneous breathing without an extra oxygen supply, no tracheotomy using metal trachea cannula, and feasible for magnetic resonance inspectors;

  4. Written informed consent from patient families

Exclusion Criteria:
  1. History of nervous or spirit disorders, or some other serious diseases such as cardiac or pulmonary problems;

  2. With contraindications of spinal cord operations.

  3. Body temperature is abnormal, vital signs are not stable, still need a ventilator to support breathing; Plentiful sputum needed suction during MRI scans.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Neurosurgery, Huashan Hospital Shanghai Shanghai China 200000

Sponsors and Collaborators

  • Huashan Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xuehai Wu, Professor, Huashan Hospital, Huashan Hospital
ClinicalTrials.gov Identifier:
NCT04010838
Other Study ID Numbers:
  • KY2017-329
First Posted:
Jul 8, 2019
Last Update Posted:
Jul 8, 2019
Last Verified:
Jul 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Xuehai Wu, Professor, Huashan Hospital, Huashan Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2019